Herbal Supplement For Patients With HIV & TB - Phase II Clinical Trial Of Botanical Immunomodulator Dzherelo (Immunoxel)

Ukrainian company Ekomed LLC announced this week that it had published Phase II clinical trial of its herbal supplement Dzherelo (Immunoxel) in patients with HIV and tuberculosis. The study appeared in June issue of International Immunopharmacology (2008; Volume 8(6): Pages 845-851). Abstract of the paper can be found online at PubMed — medical information service of the National Institutes of Health (NIH) -

More: continued here

Filed under: Complementary Medicine on June 30th, 2008